<?xml version="1.0" encoding="UTF-8"?><protocol_summary><protocol><id>14729</id><no>SAFEKIDNEY</no><status>Open (affiliates only)</status><title>Safety, tolerability and efficacy of AntiBKV as treatment of BKV infection in kidney transplant recipients, a randomized phase II/III study, double-blind and placebo-controlled</title><secondary_protocol_no>MTx-AntiBKV-US-2.01BKVI</secondary_protocol_no><nct_id>NCT05769582</nct_id><sponsor_type>Industrial</sponsor_type><age_group>Adult</age_group><treatment_type>Treatment</treatment_type><disease_site>Other</disease_site><PI>Costa, Nadiesta</PI><institution>Medstar Washington Hospital Center</institution><management_group>MedStar Medical &amp; Surgical Research Network</management_group></protocol><sipVersion>2026.1.0 Build 16</sipVersion><copyright> &lt;a href="https://advarra.com" target="_blank"&gt;&amp;copy; 2026 Advarra, Inc.&lt;/a&gt; </copyright></protocol_summary>